MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    A Need for Improving the Diet Quality of Individuals with Parkinson’s Disease

    S. Mandali, K. Lyons, R. Pahwa, A. Lee (Kansas City, USA)

    Objective: This is a quality improvement project undertaken with an aim to evaluate the diet quality and adherence to the Mediterranean diet among individuals with…
  • 2023 International Congress

    Movement disorders spectrum in CTNNB1-related neurodevelopmental disorders

    G. Garone, M. Grasso, L. Travaglini, MC. Digilio, A. Capuano, F. Nicita, G. Della Bella, D. Diodato, L. Chioma, A. Mandarino, L. Sinibaldi (Rome, Italy)

    Objective: To describe the phenomenology and clinical course of movement disorders in CTNNB1-related neurodevelopmental disorder (CTNNB1-NDD). Background: CTNNB1-NDD is a rare neurogenetic condition caused by…
  • 2023 International Congress

    Dysphagia and dopaminergic neurodegeneration in Parkinson’s Disease

    S. Polychronis, B. Ribba, G. Nasios, E. Dardiotis, G. Pagano (Ioannina, Greece)

    Objective: To evaluate the association between dysphagia and neurodegeneration of the putaminal dopaminergic system in people with early-stage treated with symptomatic therapy and advanced-stage Parkinson’s…
  • 2023 International Congress

    Essential tremor suppression using a novel anti-tremor orthosis

    W. Mugge, L. Elstgeest, M. van Ginkel, L. Pol, IJ. de Lange, N. Pambakian, A. Souza, R. Helmich, D. Kamphuis (Delft, Netherlands)

    Objective: Assess the efficacy of a novel anti-tremor orthosis in reducing hand and forearm tremor in patients with Essential Tremor in a clinical setting. Background:…
  • 2023 International Congress

    Dynamic assessment of levels of depression and anxiety impairment in Parkinson’s disease

    O. Naimov, R. Matmurodov (Tashkent, Uzbekistan)

    Objective: To dynamic assessment of depression and anxiety disorders in Parkinson's disease. Background: One of the most common nonmotor disturbances in Parkinson's disease (PD) is…
  • 2023 International Congress

    Pareidolias and color discrimination deficits differently correlate with cognitive dysfunction in prodromal Lewy body disease

    S. Kim, JH. Choi, KA. Woo, JY. Joo, HJ. Chang, B. Jeon, JY. Lee (Seoul, Republic of Korea)

    Objective: To investigate color discrimination ability and complex visual illusions known as pareidolias, and their associating factors in patients with iRBD compared to PD and…
  • 2023 International Congress

    Caffeine Intake Interacts with Gene Variants in Parkinson’s disease

    E. Tan, Y. Ong, X. Deng, H. Li, D. Heng, K. Narasimhalu, L. Chan, P. Kumar, W. Au, P. Ratnagopal, L. Tan (Singapore, Singapore)

    Objective: We investigate interactions of caffeine intake with PD risk variants and determine PD risk estimates in caffeine-drinkers carrying these variants. Background: Caffeine intake reduces…
  • 2023 International Congress

    Altered nucleus accumbens functional connectivity precedes apathy in Parkinson’s disease

    L. Morris, S. Harrison, T. Melzer, J. Dalrymple-Alford, T. Anderson, M. Macaskill, C. Le Heron (Christchurch, New Zealand)

    Objective: To investigate whether changes in connectivity between neural regions that are associated with goal-directed behaviour predict future development of apathy in people with Parkinson’s…
  • 2023 International Congress

    Towards smart glasses for improved care of individuals with Parkinson’s disease

    I. Kiprijanovska, F. Panchevski, S. Stankoski, M. Gjoreski, J. Archer, J. Broulidakis, I. Mavridou, B. Hayes, T. Guerreiro, C. Nduka, H. Gjoreski (Brighton, United Kingdom)

    Objective: To evaluate the applicability of sensor-enabled smart glasses for remote tracking of symptoms related to Parkinson’s disease Background: Diagnosis and monitoring of PD by…
  • 2023 International Congress

    Trial protocol: Randomized double blind controlled study to investigate disease modifying effect, safety and optimal dose of oral semaglutide tablet for patients with Parkinson’s disease (MOST-ABLE study)

    Y. Kimura, T. Koda, H. Kurakami, S. Sakamoto, K. Iwasaki, H. Mochizuki (Suita, Osaka, Japan)

    Objective: This study aims to assess efficacy and disease modifying effect, safety, and optimal dose of oral semaglutide tablet, glucagon-like peptide-1 receptor agonists (GLP-1RAs), for…
  • « Previous Page
  • 1
  • …
  • 169
  • 170
  • 171
  • 172
  • 173
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley